These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 39364436)

  • 21. Bariatric Surgery for Adults With Class I Obesity and Difficult-to-Manage Type 2 Diabetes: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2023; 23(8):1-151. PubMed ID: 38130940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.
    Sprague BL; Stout NK; Schechter C; van Ravesteyn NT; Cevik M; Alagoz O; Lee CI; van den Broek JJ; Miglioretti DL; Mandelblatt JS; de Koning HJ; Kerlikowske K; Lehman CD; Tosteson AN
    Ann Intern Med; 2015 Feb; 162(3):157-66. PubMed ID: 25486550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structured Education and Neuromuscular Exercise Program for Hip and/or Knee Osteoarthritis: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2018; 18(8):1-110. PubMed ID: 30443280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Home Narrowband Ultraviolet B Phototherapy for Photoresponsive Skin Conditions: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(12):1-134. PubMed ID: 33240453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic Testing for Familial Hypercholesterolemia: Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2022; 22(3):1-155. PubMed ID: 36158868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-Free Circulating Tumour DNA Blood Testing to Detect
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(5):1-176. PubMed ID: 32206157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Placental Growth Factor (PlGF)- Based Biomarker Testing to Help Diagnose Pre-eclampsia in People With Suspected Pre-eclampsia: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2023; 23(3):1-146. PubMed ID: 37284279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osseointegrated Prosthetic Implants for People With Lower-Limb Amputation: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2019; 19(7):1-126. PubMed ID: 31911825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonthermal Endovenous Procedures for Varicose Veins: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(8):1-188. PubMed ID: 34211617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implantable Devices for Single-Sided Deafness and Conductive or Mixed Hearing Loss: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(1):1-165. PubMed ID: 32194878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanical Thrombectomy for Acute and Subacute Blocked Arteries and Veins in the Lower Limbs: A Health Technology Assessment.
    Ontario Health
    Ont Health Technol Assess Ser; 2023; 23(1):1-244. PubMed ID: 36818453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(11):1-178. PubMed ID: 32194879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP (NT-proBNP) as Diagnostic Tests in Adults With Suspected Heart Failure: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(2):1-125. PubMed ID: 34055110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-surgical Nasal Decolonization of
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2022; 22(4):1-165. PubMed ID: 36160757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Level 2 Polysomnography for the Diagnosis of Sleep Disorders: A Health Technology Assessment.
    Ontario Health
    Ont Health Technol Assess Ser; 2024; 24(7):1-157. PubMed ID: 39372311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for Breast Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Henderson JT; Webber EM; Weyrich MS; Miller M; Melnikow J
    JAMA; 2024 Jun; 331(22):1931-1946. PubMed ID: 38687490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force.
    Melnikow J; Fenton JJ; Whitlock EP; Miglioretti DL; Weyrich MS; Thompson JH; Shah K
    Ann Intern Med; 2016 Feb; 164(4):268-78. PubMed ID: 26757021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton Beam Therapy for Cancer in Children and Adults: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(1):1-142. PubMed ID: 34055109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient preferences for breast cancer screening: a systematic review update to inform recommendations by the Canadian Task Force on Preventive Health Care.
    Pillay J; Guitard S; Rahman S; Saba S; Rahman A; Bialy L; Gehring N; Tan M; Melton A; Hartling L
    Syst Rev; 2024 May; 13(1):140. PubMed ID: 38807191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Testing for Thyroid Nodules of Indeterminate Cytology: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2022; 22(2):1-111. PubMed ID: 35591972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.